Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMC Med Genet. 2009 Jul 14;10:65. doi: 10.1186/1471-2350-10-65.

Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy.

Author information

  • 1Institute of Medical Microbiology and Hygiene, Charité - University Medical Center Berlin, Germany. lutz.hamann@charite.de

Abstract

BACKGROUND:

The Toll-like receptors (TLRs) mediate innate immunity to various pathogens. A mutation (S180L) in the TLR downstream signal transducer TIRAP has recently been reported to be common in Europeans and Africans and to roughly half the risks of heterogeneous infectious diseases including malaria, tuberculosis, bacteremia, and invasive pneumococal disease in heterozygous mutation carriers.

METHODS:

We assessed the TIRAP S180L variant by melting curve and RFLP analysis in 1095 delivering women from malaria-endemic Ghana, as well as in a further 1114 individuals participating in case control studies on sepsis and leprosy in Germany, Turkey and Bangladesh.

RESULTS:

In Ghana, the TIRAP S180L polymorphism was virtually absent. In contrast, the mutation was observed among 26.6%, 32.9% and 12% of German, Bangladesh and Turkish controls, respectively. No significant association of the heterozygous genotype with sepsis or leprosy was observed. Remarkably, homozygous TIRAP 180L tend to increase the risk of sepsis in the German study (P = 0.04).

CONCLUSION:

A broad protective effect of TIRAP S180L against infectious diseases per se is not discernible.

PMID:
19602285
[PubMed - indexed for MEDLINE]
PMCID:
PMC2717080
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk